Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2010
06/03/2010US20100138953 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
06/03/2010US20100138948 Transgenic plants with controlled distribution of a trait to progeny
06/03/2010US20100138947 Method for Producing Stem Cells or Stel Cell-Like Cells from Mammalian Embryos
06/03/2010US20100138944 Methods of Reducing Repeat-Induced Silencing of Transgene Expression and Improved Fluorescent Biosensors
06/03/2010US20100138940 Transgenic pig as a model of alzheimer's disease
06/03/2010US20100138939 Pig model for atherosclerosis
06/03/2010US20100138936 Transgenic Mice and Use Thereof as an Experimental Model
06/03/2010US20100138935 Detection of cellular stress
06/03/2010US20100137811 Cell handling device, tissue regeneration composition, and tissue regeneration method
06/03/2010US20100137676 N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertility
06/03/2010US20100137419 Anti-cancer agent
06/03/2010US20100137413 Micrornaome
06/03/2010US20100137412 Lentivirus pseudotyped with influenza hemagglutinin and methods of use
06/03/2010US20100137411 Ras-mediated epigenetic silencing effectors and uses thereof
06/03/2010US20100137410 Oncogenic ALL-1 Fusion Proteins for Targeting Drosha-Mediated MicroRNA Processing
06/03/2010US20100137407 Single-chain circular rna and method of producing the same
06/03/2010US20100137364 6-Aminoisoquinoline Compounds
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137356 Azaindole-indole coupled derivatives, preparation methods and uses thereof
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137229 Method Of Enhancing Lysosomal Alpha-Galactosidase A
06/03/2010US20100137221 Peptides that interact with topoisomerase i and methods thereof
06/03/2010US20100137214 Chimeric hirudin proteins
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137203 Method for preparing a cell-derived extracellular matrix membrane
06/03/2010US20100137202 Compositions for reprogramming a cell and uses therefor
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137189 Modified globin proteins with altered electron transport pathway
06/03/2010US20100137187 Glutamate-Enhanced Cell-Penetrating Peptides and Methods of Using Same
06/03/2010US20100136693 Mutants of Deoxycytidine Kinase Having Extended Enzymatic Activity
06/03/2010US20100136692 Plasmids and phages for homologous recombination and methods of use
06/03/2010US20100136691 Process for the production of a structure comprising crystalline cellulose
06/03/2010US20100136690 Slicing device
06/03/2010US20100136689 Method for decomposing biological tissue
06/03/2010US20100136688 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
06/03/2010US20100136687 Methods for Enhanced Propagation of Cells
06/03/2010US20100136686 Apparatus and method for culturing and preserving tissue constructs
06/03/2010US20100136685 Method for transferring cells to carriers and application thereof
06/03/2010US20100136684 Natural IgM Antibodies
06/03/2010US20100136683 Methods for isolating cells based on product secretion
06/03/2010US20100136682 Polyvalent RNA-Nanoparticle Compositions
06/03/2010US20100136681 Cellular compositions for the treatment of kidney disease and uses thereof
06/03/2010US20100136680 Baglike container for centrifugation and method of gene transfer using the same
06/03/2010US20100136673 Cell/tissue culturing device, system and method
06/03/2010US20100136668 Systems and methods for isolating and using clinically safe adipose derived regenerative cells
06/03/2010US20100136657 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products
06/03/2010US20100136654 Method for transcription-degradation dual regulation for protein by antibiotic
06/03/2010US20100136645 Method for preparing a cell-derived extracellular matrix scaffold
06/03/2010US20100136636 Process for selective production of theaflavin
06/03/2010US20100136628 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
06/03/2010US20100136624 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136617 Halohydrin epoxidase
06/03/2010US20100136616 Selection of Host Cells Expressing Protein at High Levels
06/03/2010US20100136605 System for and method of positioning cells and determining cellular activity thereof
06/03/2010US20100136604 In vitro tumor angiogenesis model
06/03/2010US20100136602 Sour taste receptor compositions and methods
06/03/2010US20100136598 Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells
06/03/2010US20100136597 Method for modularting activity of t lymphocytes
06/03/2010US20100136595 Hydrocarbon-forming oxidative decarbonylase enzyme, hydrocarbons produced thereby, and method of use
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136568 Compositions and Methods for Regulating RNA Translation via CD154 CA-Dinucleotide Repeat
06/03/2010US20100136537 Photoreceptor precursor cells
06/03/2010US20100136528 Fiat nucleic acids and proteins and uses thereof
06/03/2010US20100136518 Antibodies useful for therapy and diagnosis of cancer
06/03/2010US20100136514 Infectious clone of human parvovirus b19 and methods
06/03/2010US20100136512 Embryo culture media containing thyroid hormone
06/03/2010US20100136143 New compositions and methods for cell killing
06/03/2010US20100136136 JAK-2 Modulators and Methods of Use
06/03/2010US20100136113 Phytases, nucleic acids encoding them and methods for making and using them
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136061 Light-mediated anti-cell proliferative compositions and methods
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136031 Anti-cxcr1 compositions and methods
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136028 Antagonists of pcsk9
06/03/2010US20100136022 Method for modulating the immune response by activating or inactivating the notch and/or stat4 signal path
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136015 Methods and compositions for regulating iron homeostasis by modulation of bmp-6
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136009 OVR110 Antibody Compositions and Methods of Use
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135998 Combination therapy for treatment of immune disorders
06/03/2010US20100135996 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
06/03/2010US20100135993 Method of treating malignant mesothelioma
06/03/2010US20100135991 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
06/03/2010US20100135990 Modulation of NR2F6 and methods and uses thereof
06/03/2010US20100135981 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
06/03/2010US20100135975 CD133 Epitopes
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1827